Right Ventricular Outflow Tract Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 380 participants.

Also called NCT01294839

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 380 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01294839
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01294839. Randomized; triple masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2016-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Right Ventricular Outflow Tract Study
Acronym
RVOTCARE
Condition
Sinus-node Dysfunction
Intervention (Device)
Right ventricular lead location
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01294839
Content hash
0f2eaedf118fb67fe540cbc78e797fb59f78e3d141075e458c13da3211ce94f2